MAPK1 and lung adenocarcinoma: Several studies have revealed that FASN can be activated to enhance ERK2 or promote lipogenesis associated with lung adenocarcinoma and it is also expressed in the bronchial epithelium and epithelial hyperplasia in lung squamous cell cancer [31, 32].